Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

A Landscape of Driver Mutations in Melanoma

(2012) Eran Hodis et al.   CELL

Systems-Based Approaches to Cardiovascular Biomarker Discovery

(2012) Francisco J. Azuaje et al.   Circulation-Cardiovascular Genetics

Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition

(2012) Kavitha Gowrishankar et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma

(2012) Graham J. Mann et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer

(2012) Stefan Uhlmann et al.   Molecular Systems Biology

Differential network biology

(2012) Trey Ideker et al.   Molecular Systems Biology

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

(2012) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

miRNA Biomarkers in Breast Cancer Detection and Management

(2012) Sidney W. Fu et al.   Journal of Cancer

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma

(2011) Georgina V. Long et al.   JOURNAL OF CLINICAL ONCOLOGY

Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis

(2011) Sarah-Jane Schramm et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies

(2011) S.-J. Schramm et al.   MOLECULAR CANCER THERAPEUTICS

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs

(2011) Eyal Greenberg et al.   PLoS One

iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence

(2011) B. Turner et al.   Database-The Journal of Biological Databases and Curation

Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis

(2010) Chen Yao et al.   BMC Systems Biology

Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis

(2010) J.-H. Lee et al.   BRITISH JOURNAL OF DERMATOLOGY

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

(2010) József Tímár et al.   CLINICAL & EXPERIMENTAL METASTASIS

Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome

(2010) G. Jonsson et al.   CLINICAL CANCER RESEARCH

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

(2010) M. F. Segura et al.   CLINICAL CANCER RESEARCH

Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures

(2010) James Chen et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Biomarkers: The Useful and the Not So Useful—An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma

(2010) Bonnie E. Gould Rothberg et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Characterization of the Melanoma miRNAome by Deep Sequencing

(2010) Mitchell S. Stark et al.   PLoS One

Identification of high-quality cancer prognostic markers and metastasis network modules

(2010) Jie Li et al.   Nature Communications

Cancer systems biology: a network modeling perspective

(2009) P. K. Kreeger et al.   CARCINOGENESIS

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis

(2009) Bonnie E. Gould Rothberg et al.   JNCI-Journal of the National Cancer Institute

Cutaneous melanoma in the era of molecular profiling

(2009) John F Thompson et al.   LANCET

Dynamic modularity in protein interaction networks predicts breast cancer outcome

(2009) Ian W Taylor et al.   NATURE BIOTECHNOLOGY

MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism

(2009) Prasun J. Mishra et al.   PLoS One

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

(2009) D. Bogunovic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structure of Protein Interaction Networks and Their Implications on Drug Design

(2009) Takeshi Hase et al.   PLoS Computational Biology

Targeted therapy for uveal melanoma

(2008) Pierre L. Triozzi et al.   CANCER TREATMENT REVIEWS

Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma

(2008) T. John et al.   CLINICAL CANCER RESEARCH

MicroRNA Expression in Melanocytic Nevi: The Usefulness of Formalin-Fixed, Paraffin-Embedded Material for miRNA Microarray Profiling

(2008) Martin Glud et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Human Protein Reference Database--2009 update

(2008) T. S. Keshava Prasad et al.   NUCLEIC ACIDS RESEARCH

Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma

(2008) D W Müller et al.   ONCOGENE